Targeted inhibition of the molecular chaperone Hsp90 overcomes ALK inhibitor resistance in non-small cell lung cancer. Sang J, Acquaviva J, Friedland JC, Smith DL, Sequeira M, Zhang C, Jiang Q, Xue L, Lovly CM, Jimenez JP, Shaw AT, Doebele RC, He S, Bates RC, Camidge DR, Morris SW, El-Hariry I, Proia DA (2013) Cancer Discov 3: 430-43 The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. Riggs DL, Roberts PJ, Chirillo SC, Cheung-Flynn J, Prapapanich V, Ratajczak T, Gaber R, Picard D, Smith DF (2003) EMBO J 22: 1158-67 Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes. Sinars CR, Cheung-Flynn J, Rimerman RA, Scammell JG, Smith DF, Clardy J (2003) Proc Natl Acad Sci U S A 100: 868-73 Association with HSP90 inhibits Cbl-mediated down-regulation of mutant epidermal growth factor receptors. Yang S, Qu S, Perez-Tores M, Sawai A, Rosen N, Solit DB, Arteaga CL (2006) Cancer Res 66: 6990-7 High HSP90 expression is associated with decreased survival in breast cancer. Pick E, Kluger Y, Giltnane JM, Moeder C, Camp RL, Rimm DL, Kluger HM (2007) Cancer Res 67: 2932-7 Oxidative stress plays a critical role in inactivating mutant BRAF by geldanamycin derivatives. Fukuyo Y, Inoue M, Nakajima T, Higashikubo R, Horikoshi NT, Hunt C, Usheva A, Freeman ML, Horikoshi N (2008) Cancer Res 68: 6324-30 Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants. Heuckmann JM, Balke-Want H, Malchers F, Peifer M, Sos ML, Koker M, Meder L, Lovly CM, Heukamp LC, Pao W, Küppers R, Thomas RK (2012) Clin Cancer Res 18: 4682-90 Why is this effective HSP90 inhibitor not being developed in HER2+ breast cancer? Arteaga CL (2011) Clin Cancer Res 17: 4919-21 Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells. Ha K, Fiskus W, Choi DS, Bhaskara S, Cerchietti L, Devaraj SG, Shah B, Sharma S, Chang JC, Melnick AM, Hiebert S, Bhalla KN (2014) Oncotarget 5: 5637-50 Heat shock protein 90 inhibition depletes TrkA levels and signaling in human acute leukemia cells. Rao R, Nalluri S, Fiskus W, Balusu R, Joshi A, Mudunuru U, Buckley KM, Robbins K, Ustun C, Reuther GW, Bhalla KN (2010) Mol Cancer Ther 9: 2232-42 Hsp90 inhibitors promote p53-dependent apoptosis through PUMA and Bax. He K, Zheng X, Zhang L, Yu J (2013) Mol Cancer Ther 12: 2559-68 Functional specificity of co-chaperone interactions with Hsp90 client proteins. Riggs DL, Cox MB, Cheung-Flynn J, Prapapanich V, Carrigan PE, Smith DF (2004) Crit Rev Biochem Mol Biol 39: 279-95 EGFR mutant lung cancer. Gong Y, Pao W (2012) Curr Top Microbiol Immunol 355: 59-81 Physiological role for the cochaperone FKBP52 in androgen receptor signaling. Cheung-Flynn J, Prapapanich V, Cox MB, Riggs DL, Suarez-Quian C, Smith DF (2005) Mol Endocrinol 19: 1654-66 Geldanamycin leads to superoxide formation by enzymatic and non-enzymatic redox cycling. Implications for studies of Hsp90 and endothelial cell nitric-oxide synthase. Dikalov S, Landmesser U, Harrison DG (2002) J Biol Chem 277: 25480-5 Human Sgt1 binds HSP90 through the CHORD-Sgt1 domain and not the tetratricopeptide repeat domain. Lee YT, Jacob J, Michowski W, Nowotny M, Kuznicki J, Chazin WJ (2004) J Biol Chem 279: 16511-7 Heat shock protein 90 stabilization of ErbB2 expression is disrupted by ATP depletion in myocytes. Peng X, Guo X, Borkan SC, Bharti A, Kuramochi Y, Calderwood S, Sawyer DB (2005) J Biol Chem 280: 13148-52 Tumor-secreted Hsp90 subverts polycomb function to drive prostate tumor growth and invasion. Nolan KD, Franco OE, Hance MW, Hayward SW, Isaacs JS (2015) J Biol Chem 290: 8271-82 C-terminal sequences outside the tetratricopeptide repeat domain of FKBP51 and FKBP52 cause differential binding to Hsp90. Cheung-Flynn J, Roberts PJ, Riggs DL, Smith DF (2003) J Biol Chem 278: 17388-94 Endothelial nitric-oxide synthase reveals a new face in G protein signaling. Bilodeau ML, Hamm HE (2006) Mol Pharmacol 69: 677-9 The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Hartmann J, Wagner KV, Liebl C, Scharf SH, Wang XD, Wolf M, Hausch F, Rein T, Schmidt U, Touma C, Cheung-Flynn J, Cox MB, Smith DF, Holsboer F, Müller MB, Schmidt MV (2012) Neuropharmacology 62: 332-9 Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors. Regales L, Balak MN, Gong Y, Politi K, Sawai A, Le C, Koutcher JA, Solit DB, Rosen N, Zakowski MF, Pao W (2007) PLoS One 2: e810 Myocyte contractile activity modulates norepinephrine cytotoxicity and survival effects of neuregulin-1beta. Kuramochi Y, Lim CC, Guo X, Colucci WS, Liao R, Sawyer DB (2004) Am J Physiol Cell Physiol 286: C222-9 Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives. Vila A, Tallman KA, Jacobs AT, Liebler DC, Porter NA, Marnett LJ (2008) Chem Res Toxicol 21: 432-44 Protein-selective capture to analyze electrophile adduction of hsp90 by 4-hydroxynonenal. Connor RE, Marnett LJ, Liebler DC (2011) Chem Res Toxicol 24: 1275-82 Protein complex formation with heat shock protein 90 in chronic hypoxia-induced pulmonary hypertension in newborn piglets. Fike CD, Pfister SL, Slaughter JC, Kaplowitz MR, Zhang Y, Zeng H, Frye NR, Aschner JL (2010) Am J Physiol Heart Circ Physiol 299: H1190-204 Heat shock protein 90-eNOS interactions mature with postnatal age in the pulmonary circulation of the piglet. Aschner JL, Zeng H, Kaplowitz MR, Zhang Y, Slaughter JC, Fike CD (2009) Am J Physiol Lung Cell Mol Physiol 296: L555-64 Heat shock protein 90 modulates endothelial nitric oxide synthase activity and vascular reactivity in the newborn piglet pulmonary circulation. Aschner JL, Foster SL, Kaplowitz M, Zhang Y, Zeng H, Fike CD (2007) Am J Physiol Lung Cell Mol Physiol 292: L1515-25 Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies. Huth JR, Park C, Petros AM, Kunzer AR, Wendt MD, Wang X, Lynch CL, Mack JC, Swift KM, Judge RA, Chen J, Richardson PL, Jin S, Tahir SK, Matayoshi ED, Dorwin SA, Ladror US, Severin JM, Walter KA, Bartley DM, Fesik SW, Elmore SW, Hajduk PJ (2007) Chem Biol Drug Des 70: 1-12
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.